Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.diabres.2016.01.016
DC FieldValue
dc.titleMetabolic syndrome and eye diseases
dc.contributor.authorPoh, Stanley
dc.contributor.authorAbdul, Riswana Banu Binte Mohamed
dc.contributor.authorLamoureux, Ecosse L
dc.contributor.authorWong, Tien Y
dc.contributor.authorSabanayagam, Charumathi
dc.date.accessioned2020-08-20T14:46:26Z
dc.date.available2020-08-20T14:46:26Z
dc.date.issued2016-03
dc.identifier.citationPoh, Stanley, Abdul, Riswana Banu Binte Mohamed, Lamoureux, Ecosse L, Wong, Tien Y, Sabanayagam, Charumathi (2016-03). Metabolic syndrome and eye diseases. DIABETES RESEARCH AND CLINICAL PRACTICE 113 : 86-100. ScholarBank@NUS Repository. https://doi.org/10.1016/j.diabres.2016.01.016
dc.identifier.issn01688227
dc.identifier.issn18728227
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/173194
dc.description.abstract© 2016 Elsevier Ireland Ltd. Metabolic syndrome is becoming a worldwide medical and public health challenge as it has been seen increasing in prevalence over the years. Age-related eye diseases, the leading cause of blindness globally and visual impairment in developed countries, are also on the rise due to aging of the population. Many of the individual components of the metabolic syndrome have been shown to be associated with these eye diseases. However, the association of metabolic syndrome with eye diseases is not clear. In this review, we reviewed the evidence for associations between metabolic syndrome and certain ocular diseases in populations. We also reviewed the association of individual metabolic syndrome components with ocular diseases due to a paucity of research in this area. Besides, we also summarised the current understanding of etiological mechanisms of how metabolic syndrome or the individual components lead to these ocular diseases. With increasing evidence of such associations, it may be important to identify patients who are at risk of developing metabolic syndrome as prompt treatment and intervention may potentially decrease the risk of developing certain ocular diseases.
dc.publisherElsevier BV
dc.sourceElements
dc.subjectAge-related macular degeneration
dc.subjectCataract
dc.subjectDiabetic retinopathy
dc.subjectGlaucoma
dc.subjectMetabolic syndrome
dc.subjectObservational studies
dc.typeReview
dc.date.updated2020-06-03T13:46:15Z
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1016/j.diabres.2016.01.016
dc.description.sourcetitleDIABETES RESEARCH AND CLINICAL PRACTICE
dc.description.volume113
dc.description.page86-100
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Mets and eye diseases_Poh S DRCP.pdfPublished version675.45 kBAdobe PDF

CLOSED

None

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.